WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED – Trademark Portfolio

Entity Type: 11

WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include INTENSOL and DOLOPHINE. The owner is based in LONDON.

1 NEW BURLINGTON PLACE

LONDON

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

INTENSOL
INTENSOL
Registered 2018
HEP-LOCK
HEP-LOCK
Abandoned 2017
DOLOPHINE
DOLOPHINE
Registered 1947

Trademark Classifications

WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED have?

WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED file in?

WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED's most well-known trademarks?

WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED's registered trademark portfolio includes well-known marks such as INTENSOL and DOLOPHINE. These are among 2 currently registered trademarks in the portfolio.

What is WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED's trademark registration success rate?

WEST-WARD PHARMACEUTICALS INTERNATIONAL LIMITED has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.